PRF Technologies Reports Expanded Preclinical Results for PRF-110 in Head-to-Head Comparison with Approved Benchmark
Go back to PRF Technologies Reports Expanded Preclinical Results for PRF-110 in Head-to-Head Comparison with Approved Benchmark| (NASDAQ: PRFX) | Delayed: 0.95 -0.02 (2.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.97 | 52 Week High | $ | |||
| Open | $0.99 | 52 Week Low | $ | |||
| Day High | $0.99 | P/E | N/A | |||
| Day Low | $0.93 | EPS | $ | |||
| Volume | 26,250 | |||||

